Diseases [C] » Nervous System Diseases [C10] » Neuromuscular Diseases » Peripheral Nervous System Diseases
Description
Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. MeSH
Hierarchy View
Subtype Terms (20)
Amyloid Neuropathies
3 drugs (2 approved, 1 experimental)
Brachial Plexus Neuropathies
2 approved drugs
Complex Regional Pain Syndromes
25 drugs (22 approved, 3 experimental)
Diabetic Neuropathies
131 drugs (67 approved, 64 experimental)
Giant Axonal Neuropathy
1 experimental drug
Mononeuropathies
1 experimental drug
Nerve Compression Syndromes
3 drugs (2 approved, 1 experimental)
Neuralgia
148 drugs (87 approved, 61 experimental)
Neuritis
14 drugs (7 approved, 7 experimental)
Neurofibromatosis 1
51 drugs (42 approved, 9 experimental)
Pain Insensitivity, Congenital
2 approved drugs
Peripheral Nerve Injuries
43 drugs (28 approved, 15 experimental)
Peripheral Nervous System Neoplasms
1 approved drug
Polyneuropathies
22 drugs (18 approved, 4 experimental)
Radiculopathy
57 drugs (37 approved, 20 experimental)
Small Fiber Neuropathy
10 drugs (6 approved, 4 experimental)
Phase 2 Indicated Drugs (25)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (23)
Organization Involved with Phase 4 Indications (29)
Organization Involved with Phase 3 Indications (71)
Boryung Pharmaceutical Company
Dr. Negrin University Hospital
Duta Wacana Christian University
Eastern Virginia Medical School
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
Iran University of Medical Sciences
Mashhad University of Medical Sciences
Poole Hospital NHS Foundation Trust
Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)
Second Military Medical University
Organization Involved with Phase 2 Indications (146)
Bangabandhu Sheikh Mujib Medical University
BioDelivery Sciences International
Case Western Reserve University
Changchun University of Chinese Medicine
Getwell Hospital and Research Centre
Heilongjiang University of Traditional Chinese Medicine
Herbert Irving Comprehensive Cancer Center
Hunan University of Traditional Chinese Medicine
Jehangir Clinical Development Centre Pvt. Ltd.
Jilin Academy of Traditional Chinese Medicine
Jnana Sanjeevani Medical Centre
K.L.E.S Dr. Prabhakar Kore Hospital & Medical research Centre
Nasser Institute For Research and Treatment
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Neurological Disorders and Stroke (NINDS)
Nerve & Muscle Center of Texas
Neurologic AIDS Research Consortium
Oregon Health and Science University
Phoenix Neurological Associates, LTD
PNA Center for Neurological Research
Royal Marsden Hospital NHS Trust
Shaanxi Buchang Pharmaceutical Co., Ltd
Shahid Beheshti University of Medical Sciences
Shandong University of Traditional Chinese Medicine
The University of Texas, Dallas
TOTALL Diabetes Hormone Institute
Triclinium Clinical Trial Project Management
Triple O Research Institute PA
University of British Columbia
University of California, Davis
University of North Carolina at Chapel Hill
University of Southern Denmark
Virginia Commonwealth University
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (40)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
